Company Filing History:
1 out of 16 
1 out of 486 
1 out of 517 
Years Active: 2022
Title: David McDermott: Innovator in Cancer Treatment
Introduction
David McDermott is a notable inventor based in Milton, MA, who has made significant contributions to the field of cancer treatment. He holds a patent for innovative methods aimed at treating advanced forms of cancer, particularly clear cell renal cell carcinoma. His work focuses on improving patient outcomes while minimizing toxicity.
Latest Patents
David McDermott's patent, titled "Methods for treating cancer," presents groundbreaking techniques for administering X4P-001 to patients. This method is designed to reduce angiogenic escape that often occurs with TKI therapy. The results of his research demonstrate a remarkable regression in tumor size and cell number, showcasing the potential of his approach in cancer therapy.
Career Highlights
Throughout his career, David has worked with prominent organizations such as X4 Pharmaceuticals, Inc. and Georgetown University. His experience in these institutions has allowed him to develop and refine his innovative methods for cancer treatment.
Collaborations
David has collaborated with esteemed colleagues, including Robert D. Arbeit and Paula Marie Ragan, to advance his research and enhance the effectiveness of his treatments.
Conclusion
David McDermott's contributions to cancer treatment through his patented methods highlight his dedication to improving patient care. His innovative approaches continue to pave the way for advancements in oncology.